Bionano Genomics, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 11, 2026 (15 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Apr 13, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Nov 24, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $7 | 44% |
| Aug 18, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $11 | 44% |
| May 20, 2025 | Maxim Group | upgrade | Hold → Buy | $8 | 42% |
| Apr 9, 2025 | HC Wainwright & Co. | initiate | — → Buy | $10 | 44% |
| Apr 2, 2025 | Scotiabank | maintain | Sector Perform → Sector Perform | $4 | 55% |
| Nov 15, 2024 | Ladenburg Thalmann | downgrade | Buy → Neutral | $0 | 44% |
| May 16, 2024 | BTIG | maintain | Buy → Buy | $2 | 52% |
| Mar 7, 2024 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $6 | 55% |
| Nov 13, 2023 | Maxim Group | downgrade | Buy → Hold | $0 | 42% |
| Aug 10, 2023 | BTIG | maintain | Buy → Buy | $10 | 52% |
No cross-platform signals in the last 90 days